MARKET WIRECNBC • 2h ago
Here are 3 big things we're watching in the stock market in the week aheadThe market could use a few victories in the days ahead, which will be filled with more earnings, an election, and jobs data.
Why CLBT Stock surged +3.02% Today — RQD Quant Desk Flash
$12.28 +3.02% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $12.38
Cellebrite DI Ltd. (CLBT) earns a Roarable Rating of B (Buy) with 73/100 RQD Confidence. High-quality cash engine (84% profit margin, 15% return on capital) with steady institutional support. The company’s underlying cash engine and institutional positioning keep the composite score in the Green Buy zone.
ROARABLE B • BUY
Cap $3.09B
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $12.38 (+0.78%)🧬 Cannibal Buyback (-2.08% YoY Shares)⚙️ Cash Engine: 17/20 (A-) • 33.7% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record: Scores of 73/100 (B) historically ranked in the Top 13% of excess returns over the next 90 days (+7.1% avg 90D alpha vs SPY • 69.0% hit rate).
Audit Bucket Track Record →RQD QUANT TACHOMETERBUY • B
2-of-3 JEV AI Jury Bullish
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw B · Rk B
Each axis scored 0–20
12M PRICE TARGET CONE+6.8% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for CLBT)Realized 20D OHLCV Swing Band: ±7.5%
Deterministic 5-Pillar Attribution (73/100 Composite)
🔍 WHY CLBT SCORES 73/100 (B) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+18/20 pts (25% of score)
Altman Z-Score 4.95 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 8/9
▲ #2 Bullish Driver: Cash Engine Quality+17/20 pts (23% of score)
SEC XBRL FY 2025 (10-K): 33.7% FCF Margin ($160.3M FCF) & 84.2% Gross Margin
▼ #1 Drag / Risk Factor: Whale & Options Positioning11/20 pts (-9 pt drag)
Put hedging (50% put share) caps near-term gamma upside (-9 pts vs max)
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade C+$11.26-2% Next Q
65
Q2 (-2Q)Grade B-$11.03+9.7% Next Q
68
Q3 (-1Q)Grade B$12.10+1.5% Next Q
70
CurrentGrade B$12.28+7.1% Hist 90D α
73
Trajectory: C+ (65) → B (73)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER
⚔️ Adversarial Opposing Case: Why the CLBT Bull Thesis Could Fail
Even with a 73/100 (B) score, CLBT faces multiple-compression risk if 39.4x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.
⚠️ Forensic Kill-Switch #1
Priced at 39x earnings—high expectations leave less room for a lukewarm quarter.
⚠️ Forensic Kill-Switch #2
Dilution & Margin Drag: Cannibal Buyback (-2.08% YoY Shares) — any gross margin slip below 81.7% triggers an automatic RQD downgrade.
⚠️ Forensic Kill-Switch #3
Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($11.50) or 200D SMA ($13.40) invalidates the momentum regime and cuts Target Base ($13.11) toward Bear Floor ($10.07).
🎲 LIVE PREDICTION MARKET ODDS TIED TO $CLBT• $4.8M Crowd Pool • Kalshi / Polymarket Composite
Contract: “CLBT Beats Next Quarterly Revenue & EPS Consensus + Hyperscaler AI CapEx Holds Record Pace”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why CLBT Stock surged +3.02% Today — RQD Quant Desk Flash
Cellebrite DI Ltd. (CLBT) surged +3.02% to $12.28, trading at 26% of its 52-week range ($9.58 – $19.98). High-quality cash engine (84% profit margin, 15% return on capital) with steady institutional support.
- ▸Technical Tape: Trading at 26% of its 52-week range ($9.58 – $19.98) with RSI-14 at 58.1 (BULLISH MOMENTUM).
- ▸Volatility Profile: Historical 20-day realized swing band of ±7.5% around $12.28 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable B (Buy) backed by 84.2% gross margin and $160.3M annual free cash flow.
Live CLBT Headlines & Catalysts
MARKET WIRECNBC • 3h ago
Democratic Rep. Stevens endorses Rogers over El-Sayed in Michigan Senate electionHaley Stevens had lost the Democratic nomination for Senate in Michigan to Abdul El-Sayed earlier this year.
RISK WATCHReuters • 4h ago
Israeli strikes kill eight people in Gaza - medics say - ReutersIsraeli strikes kill eight people in Gaza - medics say Reuters
MARKET WIREReuters • 5h ago
Russia's FSB says minor detained over park attack threat after US tip-off - ReutersRussia's FSB says minor detained over park attack threat after US tip-off Reuters
MARKET WIREReuters • 6h ago
Iran, Qatari mediators hold third day of talks to end US-Iran war - ReutersIran, Qatari mediators hold third day of talks to end US-Iran war Reuters
CATALYSTReuters • 7h ago
Qatar surges, bucking Gulf market slide on Iran war concerns - ReutersQatar surges, bucking Gulf market slide on Iran war concerns Reuters
MARKET WIREReuters • 7h ago
OPEC+ keeps December oil output targets steady ahead of tougher call for 2027 - ReutersOPEC+ keeps December oil output targets steady ahead of tougher call for 2027 Reuters
MARKET WIREReuters • 7h ago
German ministers pledge tough action after rioters damage stores in Frankfurt - ReutersGerman ministers pledge tough action after rioters damage stores in Frankfurt Reuters
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk
Scheduled RQD Strong Buys & Whale Accumulation Briefing (CLBT Tape Review)
- ✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
- ✓Forensic Red-Light accounting & dilution traps to review on your watchlist
- ✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
CLBT // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -5.54%📐 WEDGE COMPRESSION COIL
2026-10-30O $12.24H $12.28L $12.01C $12.28VOL 1.74M
RES: $15.02SUP: $10.96SMA50: $11.50SMA200: $13.40
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
CLBT Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
30.0%/yr Implied 5Y Growth
vs. +18.6% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on CLBT today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for CLBT. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for CLBT today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (CLBT)
Technology Rank #65 of 714
⚔️ SPSC vs CLBT Full Matrix →
1. Head-to-Head Technology Peer Comparison (CLBT vs. SPSC, INTA, TDC, VIA)
Industry: Computer Software: Prepackaged Software (222 Tracked Issuers)Across 714 tracked Technology securities in the Roarable RQD universe, Cellebrite DI Ltd. (CLBT) ranks #65 by composite RQD confidence (73/100, grade B) and #252 by equity capitalization ($3.09B). Within this direct 5-issuer industry benchmark cohort, TDC leads on earnings valuation at 24.8x trailing P/E, while TDC leads on capital efficiency and profitability with 85.0% ROIC and 59.4% gross margin. SPSC currently holds the highest overall quantitative score in the immediate peer group at 74/100 (B) compared with CLBT at 73/100 (B).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| CLBT
ACTIVE
Cellebrite DI Ltd. | B | 73/100 | 39.4x | 84.2% | 14.6% | +3.02% | $3.09B | Benchmark Subject |
| SPSC SPS Commerce Inc. | B | 74/100 | 33.1x | 69.2% | 11.4% | +0.22% | $3.09B | /spsc-vs-clbt → |
| INTA Intapp Inc. | D | 49/100 | — | 74.0% | -9.9% | -3.07% | $3.00B | /inta-vs-clbt → |
| TDC Teradata Corporation | D+ | 57/100 | 24.8x | 59.4% | 85.0% | +0.76% | $3.22B | /tdc-vs-clbt → |
| VIA Via Transportation Inc. (Class A) | D- | 39/100 | — | 39.6% | -23.6% | -1.04% | $2.94B | /via-vs-clbt → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001854587In its most recent audited fiscal period (FY2025, filed 2025-12-31), Cellebrite DI Ltd. (CLBT) reported GAAP revenue of $475.7M (+18.6% vs. FY2024 revenue of $401.2M , and +46.3% cumulative change since FY2023) , GAAP net income of $78.3M, operating cash flow of $173.5M, and free cash flow of $160.3M (+29.7% YoY). On the balance sheet, CLBT closed FY2025 with $938.9M in total assets against $0 in total debt (Altman Z-Score: 4.95, Piotroski F-Score: 8/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $475.7M | $78.3M | $173.5M | $160.3M | $938.9M | — |
| FY2024 (FY) | 2024-12-31 | $401.2M | -$283.0M | $132.2M | $123.6M | $690.6M | — |
| FY2023 (FY) | 2023-12-31 | $325.1M | -$81.1M | $102.1M | $102.1M | — | — |
3. CLBT Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs CLBT stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, Cellebrite DI Ltd. (NASDAQ: CLBT) is rated B (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 73/100 at a spot price of $12.28 (+3.02% 1D, market cap $3.09B). Pillar breakdown: Fundamental Cash Engine 17/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 18/20, FRED Macro Regime Fit 12/20, and SEC Balance-Sheet Forensics 15/20. Across 714 tracked Technology issuers, CLBT ranks #65 in composite RQD confidence.
How does CLBT compare to SPSC and INTA in the Technology sector?
Within the Technology sector (Computer Software: Prepackaged Software), CLBT carries a Roarable B (73/100 RQD), trailing P/E of 39.4x, gross margin of 84.2%, and ROIC of 14.6%. By comparison, SPSC (SPS Commerce Inc.) holds a B grade (74/100 RQD, P/E 33.1x, ROIC 11.4%, cap $3.09B) and INTA (Intapp Inc.) posts a D grade (49/100 RQD, P/E N/A, ROIC -9.9%, cap $3.00B). Among the 5-stock peer group, TDC leads on earnings multiple (24.8x) while TDC leads on capital efficiency (85.0% ROIC).
What are the biggest fundamental strengths and SEC risk factors for CLBT?
Per CLBT's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001854587), Cellebrite DI Ltd. generated $475.7M in revenue (+18.6% YoY), $78.3M in net income, and $160.3M in free cash flow against $938.9M in total assets and $0 in total debt. Key quantitative strengths: Strong cash generator (84% profit margin)—profits are backed by real money, not accounting tricks.. Primary risk factors monitored: Priced at 39x earnings—high expectations leave less room for a lukewarm quarter.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is CLBT trading relative to its 50-day, 200-day, and 52-week technical levels?
CLBT last traded at $12.28 (+3.02% on volume of 2,115,840 shares), positioning the stock +6.78% above its 50-day simple moving average ($11.50) and -8.36% below its 200-day simple moving average ($13.40). Across its 52-week range of $9.58 to $19.98, CLBT sits at the 26.0% percentile with a 14-day RSI of 58.1 (BULLISH MOMENTUM) and an implied next-earnings move of ±7.5% ($11.36 to $13.20).
CLBT Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is CLBT stock moving today?
Why CLBT Stock surged +3.02% Today — RQD Quant Desk Flash. High-quality cash engine (84% profit margin, 15% return on capital) with steady institutional support.